Normal view MARC view ISBD view

Myers, L W

Immunologic therapy for secondary and primary progressive multiple sclerosis. [electronic resource] - Current neurology and neuroscience reports May 2001 - 286-93 p. digital

Publication Type: Comparative Study; Journal Article; Review

ISSN: 1528-4042

Standard No.: 10.1007/s11910-001-0032-8 doi

Subjects--Topical Terms:
Adjuvants, Immunologic--therapeutic use
Adrenal Cortex Hormones--therapeutic use
Adult
Anti-Inflammatory Agents--therapeutic use
Antilymphocyte Serum--therapeutic use
Autoimmune Diseases--classification
Cladribine--therapeutic use
Clinical Trials as Topic
Combined Modality Therapy
Cyclophosphamide--therapeutic use
Disease Progression
Double-Blind Method
Drug Administration Schedule
Drug Therapy, Combination
Forecasting
Glatiramer Acetate
Hematopoietic Stem Cell Transplantation
Humans
Immunoglobulins, Intravenous--therapeutic use
Immunosuppressive Agents--therapeutic use
Interferon beta-1a
Interferon beta-1b
Interferon-beta--therapeutic use
Middle Aged
Mitoxantrone--therapeutic use
Multicenter Studies as Topic
Multiple Sclerosis--classification
Peptides--therapeutic use
Plasma Exchange
Randomized Controlled Trials as Topic
Steroids
T-Lymphocytes--immunology
Treatment Outcome
Vaccination